HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feasibility of image-guided radiotherapy and concurrent chemotherapy for locally advanced nonsmall cell lung cancer.

Abstract
A retrospective review of 32 patients with stage III nonsmall cell lung cancer who underwent chemoradiation with image-guided radiotherapy (IGRT) was recorded. Acute grade 3-4 hematologic and esophageal toxicities developed in 6 and 13 patients respectively. At a median follow-up of 14.5 months, only one patient developed grade 3 pneumonitis. The median survival was estimated to be 17 months. Five patients (15%) developed loco-regional recurrences, and 17 patients (53%) distant metastases. Grade 3-4 toxicities remained significant during chemoradiation with IGRT. However, the reduced rate of severe pneumonitis despite a high tumor dose is encouraging and needs to be investigated in future prospective studies.
AuthorsNam P Nguyen, Sarah Kratz, Alexander Chi, Jacqueline Vock, Paul Vos, Wei Shen, Vinh-Hung Vincent, Lars Ewell, Siyoung Jang, Gabor Altdorfer, Ulf Karlsson, Juan Godinez, William Woods, Suresh Dutta, Fred Ampil, International Geriatric Radiotherapy Group
JournalCancer investigation (Cancer Invest) Vol. 33 Issue 3 Pg. 53-60 (Mar 2015) ISSN: 1532-4192 [Electronic] England
PMID25634242 (Publication Type: Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung (drug therapy, pathology, radiotherapy)
  • Chemoradiotherapy
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, pathology, radiotherapy)
  • Male
  • Middle Aged
  • Radiotherapy, Image-Guided (methods)
  • Retrospective Studies
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: